J Liver Cancer.  2015 Mar;15(1):64-69. 10.0000/jlc.2015.15.1.64.

A Case of Achieving Complete Remission with Combination of Stereotac-tic Body Radiation Therapy and Transarterial Chemoemoblization in Pa-tients with 4.8 cm Sized Infiltrative Hepatocellular Carcinoma with Arte-riovenous Shunt

• Hwang SY
• Lee SM
• Im JW
• Kim JS
• Jeon KJ
• Ahn SB
• Ji EK
• Kang HC
• Choi CW
• Yang GM

• KMID: 2154077
• DOI: http://doi.org/10.0000/jlc.2015.15.1.64

Abstract

Infiltrative hepatocellular carcinoma (HCC) patients have a poor prognosis because most patients present with advanced disease. Although tumor size is small, ablation therapy is difficult because it is difficult to delineate tumor boundary and tumor often combined vascular invasion. Therefore many clinicians still try locoregional therapy (LRT) such as transarterial chemoembolization (TACE), radiation therapy (RT), or combination with LRT and sorafenib in this situation. Stereotactic body radiation therapy (SBRT) is new technology providing very highly conformal ablative radiation dose and is expected to salvage modality for HCC showed incomplete response of TACE due to combined arteriovenous (AV) shunts. Based on above suggestions, we herein offer our experience of a complete remission of tumor by combination of SBRT and TACE in a patient with infiltrative HCC. Further study, maybe regarding a combination of locoregional and systemic therapy is necessary on how to manage infiltrative HCC with AV shunts.

Keyword

Infiltrative hepatocellular carcinoma; Arteriovenous shunt; Stereotactic body radiation therapy; Transarterial chemoembolization

MeSH Terms

Carcinoma, Hepatocellular*
Humans
Prognosis